Clearside Biomedical Inc (NAS:CLSD)
$ 1.15 0 (0%) Market Cap: 85.96 Mil Enterprise Value: 57.46 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 64/100

Q4 2023 Clearside Biomedical Inc Earnings Call Transcript

Mar 12, 2024 / 08:30PM GMT
Release Date Price: $1.64 (-18.81%)
Operator

Greetings, and welcome to the Clearside Biomedical Q4 2023 financial results and corporate update call. At this time, all participants are in a listen only mode. (Operator Instructions)

Please note this conference is being recorded I will now turn the conference over to your host, Jenny Kobin, Clearside Investor Relations. Jenny, you may begin.

Jenny Kobin
Clearside Biomedical Inc - Investor Relations

Good afternoon, everyone, and thank you for joining us on the call today. Before we begin, I would like to remind you that during today's call, we will be making certain forward-looking statements. Various remarks that we make during this call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995.

Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of our annual report on Form 10-K for the year

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot